FDA Inspection 684552 — Aurobindo Pharma Ltd

Aurobindo Pharma Ltd — FEI 3004021229

The FDA completed an inspection of Aurobindo Pharma Ltd on Sep 24, 2010 in Medchal. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection details

Classification
Official Action Indicated (OAI)
End Date
Sep 24, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Medchal (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.